Tyra Biosciences
TYRA
59 hedge funds and large institutions have $502M invested in Tyra Biosciences in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 59 → 59 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
0.3% less ownership
Funds ownership: 85.08% → 84.78% (-0.3%)
19% less capital invested
Capital invested by funds: $617M → $502M (-$115M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
+$6.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.24M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$363K |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$252K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$218K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.23M |
| 2 |
JP Morgan Chase
New York
|
-$383K |
| 3 |
JAFL
Jay A. Fishman Ltd
Troy,
Michigan
|
-$375K |
| 4 |
Millennium Management
New York
|
-$368K |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$351K |
TYRA Hedge Fund Activity: Q3 2023 in Review
59 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q3 2023, worth a combined $502M — down 19% from $617M a quarter earlier.
Fund positioning in TYRA was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 16 added to existing stakes and 16 trimmed.
The largest buyer was 5AM Venture Management, opening a new position worth an estimated $6.1M. The largest seller was Fidelity Investments, cutting an estimated $3.23M.
- 59 institutional investors held Tyra Biosciences (TYRA) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $502M of Tyra Biosciences stock for Q3 2023, down 19% quarter-over-quarter.
- 4 funds opened new Tyra Biosciences positions in Q3 2023 and 4 closed out, a net change of 0 holders.
- The largest Tyra Biosciences buyer in Q3 2023 was 5AM Venture Management, an estimated $6.1M added.
- The largest Tyra Biosciences seller in Q3 2023 was Fidelity Investments, an estimated $3.23M sold.
Based on aggregated 13F filings for Q3 2023.